vs
NOVAVAX INC（NVAX）与Resolute Holdings Management, Inc.（RHLD）财务数据对比。点击上方公司名可切换其他公司
NOVAVAX INC的季度营收约是Resolute Holdings Management, Inc.的1.3倍（$147.3M vs $117.7M），NOVAVAX INC净利率更高（11.9% vs -1.5%，领先13.4%），Resolute Holdings Management, Inc.自由现金流更多（$189.2M vs $-41.6M）
诺瓦瓦克斯是一家总部位于美国马里兰州盖瑟斯堡的生物科技企业，专注于传染病疫苗研发。其开发的新冠疫苗现由赛诺菲负责商业化，同时还在布局流感、呼吸道合胞病毒（RSV）、禽流感、带状疱疹、艰难梭菌感染、疟疾等多个领域的疫苗管线。
Resolute Holdings Management, Inc.是一家澳大利亚矿业企业，核心业务布局于非洲地区，目前运营两座金矿，分别为位于马里的 Syama 金矿和塞内加尔的 Mako 金矿，专注于黄金资源的勘探、开采及相关运营管理工作。
NVAX vs RHLD — 直观对比
营收规模更大
NVAX
是对方的1.3倍
$117.7M
净利率更高
NVAX
高出13.4%
-1.5%
自由现金流更多
RHLD
多$230.8M
$-41.6M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $147.3M | $117.7M |
| 净利润 | $17.5M | $-1.7M |
| 毛利率 | 85.0% | 55.7% |
| 营业利润率 | 9.7% | 30.2% |
| 净利率 | 11.9% | -1.5% |
| 营收同比 | 66.8% | — |
| 净利润同比 | 121.6% | — |
| 每股收益（稀释后） | $0.28 | $-0.20 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NVAXRHLD
| Q4 25 | $147.3M | $117.7M | ||
| Q3 25 | $70.4M | $120.9M | ||
| Q2 25 | $239.2M | $119.6M | ||
| Q1 25 | $666.5M | $103.9M | ||
| Q4 24 | $88.3M | — | ||
| Q3 24 | $84.5M | — | ||
| Q2 24 | $415.5M | — | ||
| Q1 24 | $93.9M | — |
净利润NVAXRHLD
| Q4 25 | $17.5M | $-1.7M | ||
| Q3 25 | $-202.4M | $-231.0K | ||
| Q2 25 | $106.5M | $-611.0K | ||
| Q1 25 | $518.6M | $-3.4M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-121.3M | — | ||
| Q2 24 | $162.4M | — | ||
| Q1 24 | $-147.6M | — |
毛利率NVAXRHLD
| Q4 25 | 85.0% | 55.7% | ||
| Q3 25 | 69.5% | 59.0% | ||
| Q2 25 | 93.6% | 57.5% | ||
| Q1 25 | 97.9% | 52.5% | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 28.3% | — | ||
| Q2 24 | 88.9% | — | ||
| Q1 24 | 36.9% | — |
营业利润率NVAXRHLD
| Q4 25 | 9.7% | 30.2% | ||
| Q3 25 | -252.7% | 34.3% | ||
| Q2 25 | 42.2% | 34.0% | ||
| Q1 25 | 77.4% | 24.7% | ||
| Q4 24 | — | — | ||
| Q3 24 | -158.6% | — | ||
| Q2 24 | 38.7% | — | ||
| Q1 24 | -154.3% | — |
净利率NVAXRHLD
| Q4 25 | 11.9% | -1.5% | ||
| Q3 25 | -287.3% | -0.2% | ||
| Q2 25 | 44.5% | -0.5% | ||
| Q1 25 | 77.8% | -3.2% | ||
| Q4 24 | — | — | ||
| Q3 24 | -143.5% | — | ||
| Q2 24 | 39.1% | — | ||
| Q1 24 | -157.2% | — |
每股收益（稀释后）NVAXRHLD
| Q4 25 | $0.28 | $-0.20 | ||
| Q3 25 | $-1.25 | $-0.03 | ||
| Q2 25 | $0.62 | $-0.07 | ||
| Q1 25 | $2.93 | $-0.39 | ||
| Q4 24 | — | — | ||
| Q3 24 | $-0.76 | — | ||
| Q2 24 | $0.99 | — | ||
| Q1 24 | $-1.05 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $735.1M | $205.5M |
| 总债务越低越好 | — | $169.8M |
| 股东权益账面价值 | $-127.8M | $6.5M |
| 总资产 | $1.2B | $333.4M |
| 负债/权益比越低杠杆越低 | — | 26.03× |
8季度趋势，按日历期对齐
现金及短期投资NVAXRHLD
| Q4 25 | $735.1M | $205.5M | ||
| Q3 25 | $762.9M | $148.0M | ||
| Q2 25 | $612.3M | $99.9M | ||
| Q1 25 | $731.5M | $71.0M | ||
| Q4 24 | $923.1M | — | ||
| Q3 24 | $909.5M | — | ||
| Q2 24 | $1.0B | — | ||
| Q1 24 | $480.6M | — |
总债务NVAXRHLD
| Q4 25 | — | $169.8M | ||
| Q3 25 | — | $173.4M | ||
| Q2 25 | — | $177.1M | ||
| Q1 25 | — | $180.7M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益NVAXRHLD
| Q4 25 | $-127.8M | $6.5M | ||
| Q3 25 | $-156.7M | $10.8M | ||
| Q2 25 | $37.6M | $9.6M | ||
| Q1 25 | $-75.6M | $8.9M | ||
| Q4 24 | $-623.8M | — | ||
| Q3 24 | $-526.4M | — | ||
| Q2 24 | $-431.7M | — | ||
| Q1 24 | $-867.1M | — |
总资产NVAXRHLD
| Q4 25 | $1.2B | $333.4M | ||
| Q3 25 | $1.2B | $293.2M | ||
| Q2 25 | $1.3B | $253.3M | ||
| Q1 25 | $1.3B | $214.3M | ||
| Q4 24 | $1.6B | — | ||
| Q3 24 | $1.7B | — | ||
| Q2 24 | $1.8B | — | ||
| Q1 24 | $1.4B | — |
负债/权益比NVAXRHLD
| Q4 25 | — | 26.03× | ||
| Q3 25 | — | 16.01× | ||
| Q2 25 | — | 18.42× | ||
| Q1 25 | — | 20.38× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-39.5M | $196.1M |
| 自由现金流经营现金流 - 资本支出 | $-41.6M | $189.2M |
| 自由现金流率自由现金流/营收 | -28.2% | 160.8% |
| 资本支出强度资本支出/营收 | 1.4% | 5.8% |
| 现金转化率经营现金流/净利润 | -2.25× | — |
| 过去12个月自由现金流最近4个季度 | $-250.2M | $313.2M |
8季度趋势，按日历期对齐
经营现金流NVAXRHLD
| Q4 25 | $-39.5M | $196.1M | ||
| Q3 25 | $107.8M | $59.6M | ||
| Q2 25 | $-127.5M | $48.9M | ||
| Q1 25 | $-185.5M | $18.4M | ||
| Q4 24 | $-87.3M | — | ||
| Q3 24 | $-144.8M | — | ||
| Q2 24 | $314.3M | — | ||
| Q1 24 | $-83.6M | — |
自由现金流NVAXRHLD
| Q4 25 | $-41.6M | $189.2M | ||
| Q3 25 | $105.8M | $58.6M | ||
| Q2 25 | $-127.7M | $47.5M | ||
| Q1 25 | $-186.7M | $17.8M | ||
| Q4 24 | $-100.3M | — | ||
| Q3 24 | $-146.2M | — | ||
| Q2 24 | $311.4M | — | ||
| Q1 24 | $-90.4M | — |
自由现金流率NVAXRHLD
| Q4 25 | -28.2% | 160.8% | ||
| Q3 25 | 150.2% | 48.5% | ||
| Q2 25 | -53.4% | 39.7% | ||
| Q1 25 | -28.0% | 17.1% | ||
| Q4 24 | -113.6% | — | ||
| Q3 24 | -173.0% | — | ||
| Q2 24 | 74.9% | — | ||
| Q1 24 | -96.4% | — |
资本支出强度NVAXRHLD
| Q4 25 | 1.4% | 5.8% | ||
| Q3 25 | 2.9% | 0.8% | ||
| Q2 25 | 0.1% | 1.2% | ||
| Q1 25 | 0.2% | 0.6% | ||
| Q4 24 | 14.8% | — | ||
| Q3 24 | 1.6% | — | ||
| Q2 24 | 0.7% | — | ||
| Q1 24 | 7.3% | — |
现金转化率NVAXRHLD
| Q4 25 | -2.25× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -1.20× | — | ||
| Q1 25 | -0.36× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 1.94× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NVAX
| Licensing Royalties And Other | $107.9M | 73% |
| Products | $39.2M | 27% |
RHLD
暂无分部数据
